Pressure BioSciences Statistics
Total Valuation
Pressure BioSciences has a market cap or net worth of 184,352. The enterprise value is 27.28 million.
| Market Cap | 184,352 |
| Enterprise Value | 27.28M |
Important Dates
The last earnings date was Tuesday, November 19, 2024.
| Earnings Date | Nov 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Pressure BioSciences has 40.97 million shares outstanding. The number of shares has increased by 132.88% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 40.97M |
| Shares Change (YoY) | +132.88% |
| Shares Change (QoQ) | +23.12% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | n/a |
| Float | 40.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.74 |
| EV / Sales | 17.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.89 |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.86 |
| Interest Coverage | -0.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -99.81% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 99,151 |
| Profits Per Employee | -2.29M |
| Employee Count | 16 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.02% in the last 52 weeks. The beta is -0.26, so Pressure BioSciences's price volatility has been lower than the market average.
| Beta (5Y) | -0.26 |
| 52-Week Price Change | -99.02% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 37.65 |
| Average Volume (20 Days) | 9,315 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, Pressure BioSciences had revenue of 1.59 million and -36.62 million in losses. Loss per share was -1.25.
| Revenue | 1.59M |
| Gross Profit | 533,537 |
| Operating Income | -7.35M |
| Pretax Income | -30.53M |
| Net Income | -36.62M |
| EBITDA | -7.19M |
| EBIT | -7.35M |
| Loss Per Share | -1.25 |
Balance Sheet
The company has 3,220 in cash and 27.10 million in debt, giving a net cash position of -27.09 million or -0.66 per share.
| Cash & Cash Equivalents | 3,220 |
| Total Debt | 27.10M |
| Net Cash | -27.09M |
| Net Cash Per Share | -0.66 |
| Equity (Book Value) | -38.13M |
| Book Value Per Share | -0.81 |
| Working Capital | -43.61M |
Cash Flow
In the last 12 months, operating cash flow was -4.62 million and capital expenditures -4,495, giving a free cash flow of -4.63 million.
| Operating Cash Flow | -4.62M |
| Capital Expenditures | -4,495 |
| Free Cash Flow | -4.63M |
| FCF Per Share | -0.11 |
Margins
| Gross Margin | 33.63% |
| Operating Margin | -463.32% |
| Pretax Margin | -1,924.51% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -291.72% |
Dividends & Yields
Pressure BioSciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -132.88% |
| Shareholder Yield | -132.88% |
| Earnings Yield | -27,745.33% |
| FCF Yield | -2,510.34% |
Stock Splits
The last stock split was on June 5, 2017. It was a reverse split with a ratio of 0.033333.
| Last Split Date | Jun 5, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.033333 |
Scores
Pressure BioSciences has an Altman Z-Score of -46.19. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -46.19 |
| Piotroski F-Score | n/a |